ArticleCureus2025
A Case Report of Sweet Syndrome and Hemorrhagic Bullae Associated With Acute Myeloid Leukemia With Myelodysplasia-Related Changes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sweet syndrome is a rare condition characterized as a febrile neutrophilic dermatosis. We present an atypical presentation of Sweet syndrome in female patient in her late 80s, characterized by acute fever, concurrent pancytopenia, and a unique constellation of cutaneous findings consisting of painful papulonodular lesions and hemorrhagic bullae with compatible histopathology, underscoring the necessity for clinicians to consider acute myeloid leukemia with myelodysplasia-related changes as a potential comorbidity in Sweet syndrome, particularly in cases with comparable clinical features. This report is particularly significant as it demonstrates the rapid clinical deterioration and emergence of complications, culminating in an unfavorable outcome despite early therapeutic intervention. The infrequent reporting of this unique presentation highlights the need for further exploration of its diagnostic and management relevance in patients with Sweet syndrome who exhibit hemorrhagic bullae manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.